BR0014314A - Processo para derivados de ácido fenilacético - Google Patents

Processo para derivados de ácido fenilacético

Info

Publication number
BR0014314A
BR0014314A BR0014314-6A BR0014314A BR0014314A BR 0014314 A BR0014314 A BR 0014314A BR 0014314 A BR0014314 A BR 0014314A BR 0014314 A BR0014314 A BR 0014314A
Authority
BR
Brazil
Prior art keywords
compound
formula
derivatives
phenylacetic acid
precursors
Prior art date
Application number
BR0014314-6A
Other languages
English (en)
Inventor
Murat Acemoglu
Thomas Allmendinger
John Vicent Calienni
Jacques Cercus
Olivier Loiseleur
Gottfried Sedelmeier
David Xu
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BR0014314A publication Critical patent/BR0014314A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/43—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C211/44—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring
    • C07C211/52—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/43—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C211/54—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to two or three six-membered aromatic rings
    • C07C211/56—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to two or three six-membered aromatic rings the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/22—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from lactams, cyclic ketones or cyclic oximes, e.g. by reactions involving Beckmann rearrangement
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/40—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/42—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/12—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups
    • C07C233/15—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/16—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/18—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides
    • C07C235/24—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Indole Compounds (AREA)

Abstract

"PROCESSO PARA DERIVADOS DE áCIDO FENI-LACéTICO". A invenção refere-se a um processo para a produção de um composto de Fórmula I, ou um sal farmaceuticamente aceitável do mesmo, ou um éster de pró-droga farmaceuticamente aceitável do composto, processo este que compreende clivar uma lactama de fórmula II onde os símbolos são como definidos, com uma base; e a precursores para o composto e a processos para a preparação dos precursores. Os compostos de Fórmula I são compostos farmaceuticamente ativos que são inibidores seletivos de ciclooxigenase II.
BR0014314-6A 1999-09-27 2000-09-25 Processo para derivados de ácido fenilacético BR0014314A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9922830.6A GB9922830D0 (en) 1999-09-27 1999-09-27 Processes
PCT/EP2000/009346 WO2001023346A2 (en) 1999-09-27 2000-09-25 Process for phenylacetic acid derivatives

Publications (1)

Publication Number Publication Date
BR0014314A true BR0014314A (pt) 2002-11-12

Family

ID=10861676

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0014314-6A BR0014314A (pt) 1999-09-27 2000-09-25 Processo para derivados de ácido fenilacético

Country Status (34)

Country Link
US (2) US20080249318A1 (pt)
EP (2) EP2275403A1 (pt)
JP (1) JP2003510303A (pt)
KR (1) KR100745341B1 (pt)
CN (1) CN100412053C (pt)
AR (2) AR031529A1 (pt)
AT (1) ATE447547T1 (pt)
AU (1) AU775416B2 (pt)
BR (1) BR0014314A (pt)
CA (1) CA2379553C (pt)
CO (1) CO5210865A1 (pt)
CY (1) CY1110539T1 (pt)
CZ (1) CZ20021027A3 (pt)
DE (1) DE60043261D1 (pt)
DK (1) DK1216226T3 (pt)
EC (2) ECSP003680A (pt)
ES (1) ES2338209T3 (pt)
GB (1) GB9922830D0 (pt)
HK (1) HK1047739A1 (pt)
HU (1) HUP0202728A3 (pt)
IL (2) IL148330A0 (pt)
MY (1) MY125201A (pt)
NO (1) NO327912B1 (pt)
NZ (1) NZ517461A (pt)
PE (1) PE20010644A1 (pt)
PL (1) PL207777B1 (pt)
PT (1) PT1216226E (pt)
RU (1) RU2273628C2 (pt)
SI (1) SI1216226T1 (pt)
SK (1) SK287241B6 (pt)
TR (1) TR200200745T2 (pt)
TW (1) TWI270540B (pt)
WO (1) WO2001023346A2 (pt)
ZA (1) ZA200202367B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0209257D0 (en) * 2002-04-23 2002-06-05 Novartis Ag Organic compounds
EP1539134A4 (en) 2002-06-11 2007-04-11 Nitromed Inc SELECTIVE INHIBITORS OF CYCLOOXIGENASE-2 NITROSIS AND / OR NITROSYLES, COMPOSITIONS AND METHODS OF USE
GB0224198D0 (en) * 2002-10-17 2002-11-27 Novartis Ag Organic compounds
PE20040844A1 (es) 2002-11-26 2004-12-30 Novartis Ag Acidos fenilaceticos y derivados como inhibidores de la cox-2
US7161026B1 (en) 2005-07-08 2007-01-09 Property Development Corporation International, Ltd, Inc. Method of preparation of methyl-benzyl-ketone
AR061623A1 (es) 2006-06-26 2008-09-10 Novartis Ag Derivados de acido fenilacetico
US8227451B2 (en) 2008-11-12 2012-07-24 Auspex Pharmaceuticals Phenylacetic acid inhibitors of cyclooxygenase
CN102311355B (zh) * 2011-09-26 2014-02-05 扬州天和药业有限公司 罗本考昔的一种制备方法
CN107721901A (zh) * 2017-11-12 2018-02-23 刘磊 一种2‑[2‑(2,3,5,6‑四氟苯胺基)苯基]乙酸的制备方法
WO2020021077A1 (en) 2018-07-27 2020-01-30 Krka, D.D., Novo Mesto A process for the preparation of polymorphic form of robenacoxib
WO2020027258A1 (ja) * 2018-08-03 2020-02-06 日産化学株式会社 フッ化芳香族第二級アミン化合物の製造方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3558690A (en) * 1965-04-08 1971-01-26 Gelgy Chemical Corp Substituted derivatives of 2-anilinophenylacetic acids and a process of preparation
IT1097265B (it) 1978-06-23 1985-08-31 Acraf Nouva sintesi di un acido fenilacetico
JPS5677246A (en) * 1980-11-27 1981-06-25 Nissan Chem Ind Ltd Production of substituted phenylacetic acid
DE3404401C2 (de) 1984-02-08 1994-02-10 Hoechst Ag Verwendung von Aryloxy-Verbindungen als Antidots
FR2578836B1 (fr) 1985-03-12 1987-04-17 Rhone Poulenc Spec Chim Procede de chloration selective de composes phenoliques
ES2065928T3 (es) 1989-01-27 1995-03-01 Heumann Pharma Gmbh & Co Procedimiento para la fabricacion de derivados de acido 2,6-diclorodifenilaminacetico.
IT1248032B (it) * 1991-06-11 1995-01-05 Laboratorio Chimico Int Spa Procedimento per la preparazione della n- (2,6-diclorofenil) -n-fenil-n-(cloroacetil)-ammina.
CN1091420A (zh) * 1993-02-25 1994-08-31 永信药品工业股份有限公司 二苯胺衍生物的制备方法
JPH0789951A (ja) * 1993-06-03 1995-04-04 Sterling Winthrop Inc インターロイキン−１β転換酵素阻害剤
US5475139A (en) * 1993-10-22 1995-12-12 Yung Shin Pharm. Ind. Co., Ltd. Method for the preparation of substituted derivatives of diphenyl amine
CA2189036A1 (en) 1994-04-29 1995-11-09 Roland E. Dolle Halomethyl amides as il-1.beta. protease inhibitors
US5576460A (en) * 1994-07-27 1996-11-19 Massachusetts Institute Of Technology Preparation of arylamines
JPH0977664A (ja) * 1995-09-13 1997-03-25 Yakult Honsha Co Ltd シクロオキシゲナーゼ−２特異的阻害剤及び抗炎症剤
US6355680B1 (en) * 1996-02-20 2002-03-12 Exocell, Inc. Albumin-binding compounds that prevent nonenzymatic glycation and that may be used for treatment of glycation-related pathologies
US6034266A (en) * 1996-03-11 2000-03-07 Fundacao Oswaldo Cruz-Fiocruz Gem-difluoro derivative of phenylacetamide and phenylacetic acid and their pharmaceutical uses
BR9600975A (pt) * 1996-03-11 1997-12-30 Fundacao Oswaldo Cruz Derivados do ácido gem-difluorfenilacético e de gem-difluorfenilacetamida processo de sua preparação e suas aplicações farmacêuticas
CA2208900C (en) 1996-07-18 2006-08-01 Lonza Ag Process for preparing 2-pyrimidinecarboxylates
US5817877A (en) * 1996-09-23 1998-10-06 Yale University Metal-catalyzed amination of organic sulfonates to organic amines
CO4960662A1 (es) * 1997-08-28 2000-09-25 Novartis Ag Ciertos acidos 5-alquil-2-arilaminofenilaceticos y sus derivados

Also Published As

Publication number Publication date
IL148330A (en) 2007-02-11
KR20020030289A (ko) 2002-04-24
CY1110539T1 (el) 2015-04-29
TWI270540B (en) 2007-01-11
PL207777B1 (pl) 2011-01-31
ECSP003680A (es) 2002-04-23
MY125201A (en) 2006-07-31
EP1216226B1 (en) 2009-11-04
CN1377337A (zh) 2002-10-30
IL148330A0 (en) 2002-09-12
TR200200745T2 (tr) 2002-06-21
NO327912B1 (no) 2009-10-19
PE20010644A1 (es) 2001-06-15
RU2273628C2 (ru) 2006-04-10
NZ517461A (en) 2003-10-31
AR042404A2 (es) 2005-06-22
EP2275403A1 (en) 2011-01-19
CN100412053C (zh) 2008-08-20
US20080249318A1 (en) 2008-10-09
HUP0202728A2 (hu) 2002-12-28
PT1216226E (pt) 2009-12-17
EP1216226A2 (en) 2002-06-26
CZ20021027A3 (cs) 2002-07-17
PL365994A1 (en) 2005-01-24
SK4142002A3 (en) 2002-08-06
DE60043261D1 (de) 2009-12-17
JP2003510303A (ja) 2003-03-18
HUP0202728A3 (en) 2003-11-28
AU775416B2 (en) 2004-07-29
ECSP093680A (es) 2009-02-27
CO5210865A1 (es) 2002-10-30
NO20021368D0 (no) 2002-03-19
AU7906700A (en) 2001-04-30
CA2379553A1 (en) 2001-04-05
WO2001023346A2 (en) 2001-04-05
DK1216226T3 (da) 2010-02-01
ZA200202367B (en) 2003-02-26
SK287241B6 (sk) 2010-04-07
HK1047739A1 (en) 2003-03-07
AR031529A1 (es) 2003-09-24
NO20021368L (no) 2002-05-27
SI1216226T1 (sl) 2010-03-31
WO2001023346A3 (en) 2002-01-10
US7906677B2 (en) 2011-03-15
KR100745341B1 (ko) 2007-08-02
CA2379553C (en) 2010-09-21
ES2338209T3 (es) 2010-05-05
GB9922830D0 (en) 1999-11-24
ATE447547T1 (de) 2009-11-15
US20090275758A1 (en) 2009-11-05

Similar Documents

Publication Publication Date Title
BR9401482A (pt) 1H-Indol-3-acetamida, formulação farmacêutica, utilização de um composto e processo para a preparação de 1h-indol-3-acetamida
BRPI0509588A (pt) derivados e tetraidronaftiridina e um processo para preparação dos mesmos
BR0008188A (pt) Inibidores de fator de diferenciação de crescimento e usos para os mesmos
ES2189357T3 (es) Compustos isocromano y procedimiento para su produccion.
DE69830504D1 (de) Antithrombotische mitteln
BR0010555A (pt) Inibidores de neuraminidases
AR024944A1 (es) Amidas de acidos carboxilicos, medicamentos que contienen estos compuestos, su utilizacion y su preparacion
ECSP093680A (es) Proceso para derivados del acido fenilacetico
DE50011034D1 (de) N-substituierte 4-aminopteridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
BR0315662A (pt) Derivados de 1-(4-benzil-piperazin-1-il)-3-fenil-propenona
BR9909739A (pt) Benzotiadiazóis e derivados
BR0211291A (pt) Derivados de diamina, processo para produção dos derivados de diamina e fungicidas contendo os derivados de diamina como ingrediente ativo
DE69707372D1 (de) Verwendung eines Phosphorsäurediesters zur Herstellung eines Arzneimittels zur Behandlung von Akne
BR0010225A (pt) Composto de amida, processo para prepará-lo, composição farmacêutica compreendendo dito composto, método de tratamento e uso
BR0112745A (pt) Processo para a preparação de arilacetilaminotiazóis
BR0314966A (pt) Processo para preparar um composto, e, composto
BRPI0411308A (pt) composto, composição farmacêutica, processo para a preparação de um composto, e, uso de um composto
BR9909898A (pt) Processo para purificação de um derivado de cefalosporina
BR9911250A (pt) Processo para preparação de compostos
BR9811348A (pt) Compostos derivados de indol, processo para preparação dos mesmos, e, composições farmacêuticas.
BR0016638B1 (pt) compostos anÁlogos de homopiperidilbenzimidazàis substituÍdos como relaxantes féndicos, processo para preparar os mesmos, composiÇço farmacÊutica e processo para preparÁ-la.
ATE250057T1 (de) Verfahren zur herstellung von 1-(1h)- benzoquinolizin-3-on derivaten
BR0013751A (pt) Processo para produção de derivados de ácido naftiridina-3-carboxìlico
BR0014759A (pt) Inibidores de metaloprotease beta dissubstituìdos
MXPA04000485A (es) Uso de acidos aril o heteroaril hidroxamicos de sulfonilo y derivados de los mismos como inhibidores de agrecanasa.

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]

Free format text: DE ACORDO COM O ART.34 "II" DA LPI (LEI 9279, DE 14/05/96), O EXAME FICA SUSPENSO PARA QUE O REQUERENTE APRESENTE DOCUMENTOS NECESSARIOS A REGULARIZACAO DO PROCESSO E EXAME DO PEDIDO.

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07F Notification of approval that there is no relation to art. 229 of lpi (pipeline patents) [chapter 7.6 patent gazette]

Free format text: NOTIFICACAO DE NAO ANUENCIA RELACIONADA COM O ART. 229 DA LPI

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 13A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2257 DE 08/04/2014.